Abstract
The invention relates to methods and biomarker for evaluating cancer metastasis, pharmaceutical composition for inhibiting cancer metastasis,
and method for analyzing secretome. By combining a hollow fiber cartridge (HFC) culture system with quantitative proteomics technology,
cancer metastasis-related secrectomes can be found. Furthermore, this is the first time to use PARK7 as a biomarker for judging the process of non-small cell lung cancer.
| Translated title of the contribution | 癌症轉移之評估方法及生物標記、抑制癌症轉移之醫藥組成物、及分泌蛋白質體之分析方法 |
|---|---|
| Original language | English |
| Patent number | 9194005 |
| Publication status | Published - 1800 |
